Active Pharmaceutical Ingredient (API) Products Market Size & Growth Report- Size, Share, Trends & Forecast
Market Overview
The active pharmaceutical ingredient (API) is a crucial component in the pharmaceutical industry as it determines the efficacy and safety of a drug. An API is the biologically active substance in a drug product that is responsible for the therapeutic effect. The API is combined with excipients, which are inactive substances that serve as a medium for the API, to form a final drug product. The API market is a rapidly growing industry, driven by the increasing demand for generic drugs, rising incidence of chronic diseases, and advancements in technology.
The global API market size was valued at USD 195.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2021 to 2028. The growth of the API market is driven by the increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, and the growing demand for generic drugs. Additionally, the increasing investment in research and development, advancements in technology, and increasing demand for specialty drugs are also contributing to the growth of the API market.
?
Visit this Page for More Information: Start a Business in API Industry
?
Market Segmentation
The API market is segmented based on product type, application, and geography.
·????????Based on product type
The API market is segmented into synthetic APIs, biotech APIs, and hormones and peptides. The synthetic API segment is further sub-segmented into small molecules and macromolecules. The synthetic API segment dominated the API market in 2020 and is expected to continue its dominance during the forecast period. This is due to the increasing demand for generic drugs, the large number of synthetic APIs in the market, and their low cost compared to biotech APIs.
·????????Based on application
The API market is segmented into cardiovascular diseases, oncology, central nervous system disorders, respiratory diseases, and others. The cardiovascular disease segment dominated the API market in 2020, due to the increasing incidence of cardiovascular diseases, such as hypertension and coronary artery disease, and the increasing demand for cardiovascular drugs.
?
Read our Books Here: Handbook on Active Pharmaceutical Ingredients (API), Drugs & Pharmaceutical Products
?
·????????Geographically
The API market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominated the API market in 2020, due to the presence of a large number of pharmaceutical and biotechnology companies, the presence of a developed healthcare infrastructure, and the increasing demand for generic drugs. The Asia-Pacific region is expected to grow at the fastest rate during the forecast period, due to the increasing prevalence of chronic diseases, the increasing demand for generic drugs, and the increasing investment in the pharmaceutical industry in the region.
Key Players
The API market is highly fragmented, with a large number of local and global players. Some of the key players in the API market include Pfizer Inc., Merck & Co., Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., and Mylan N.V. These players are focusing on strategic initiatives, such as mergers and acquisitions, collaborations, and partnerships, to expand their product portfolios and increase their market share.
Market Dynamics
??Drivers
Increasing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, is driving the growth of the API market. The increasing demand for drugs to treat these diseases is driving the demand for APIs.
Growing Demand for Generic Drugs: The growing demand for generic drugs is driving the growth of the API market. The increasing adoption of generic drugs, due to their lower cost compared to branded drugs, is driving the demand for APIs. Additionally, the increasing pressure to reduce healthcare costs and the expiry of patents on several branded drugs are also driving the demand for generic drugs and APIs.
?
Related Feasibility Study Reports: Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing
?
Advancements in Technology: The advancements in technology, such as biotechnology and synthetic chemistry, are driving the growth of the API market. The development of new technologies for the synthesis of APIs is enabling the development of new drugs, which is driving the demand for APIs.
Increasing Investment in Research and Development: The increasing investment in research and development in the pharmaceutical industry is driving the growth of the API market. The investment in R&D is enabling the development of new drugs, which is driving the demand for APIs.
??Restraints
Stringent Regulatory Requirements: The stringent regulatory requirements for the approval of APIs and drugs are a major restraint for the growth of the API market. The long and complex approval process, coupled with the high cost of compliance, is a major challenge for API manufacturers.
Intellectual Property Concerns: Intellectual property concerns are a major restraint for the growth of the API market. The protection of intellectual property rights, such as patents, is a major challenge for API manufacturers. Additionally, the increasing number of generic drugs in the market is also challenging the protection of intellectual property rights.
??Opportunities
Growing Demand for Specialty Drugs: The growing demand for specialty drugs is presenting a significant opportunity for the growth of the API market. The increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, is driving the demand for specialty drugs, which is driving the demand for APIs.
Emerging Markets: The emerging markets, such as Asia-Pacific and Latin America, are presenting a significant opportunity for the growth of the API market. The increasing prevalence of chronic diseases, the increasing demand for generic drugs, and the increasing investment in the pharmaceutical industry in these regions are driving the demand for APIs.
However, the API market is also facing several challenges, such as the stringent regulatory requirements and the intellectual property concerns. The API manufacturers need to focus on addressing these challenges and adapting to the changing market conditions to sustain their growth in the API market. The API market is expected to remain highly competitive, with a large number of players competing for market share. The key players in the API market are expected to focus on strategic initiatives, such as mergers and acquisitions, collaborations, and partnerships, to expand their product portfolios and increase their market share.
To remain competitive in the API market, API manufacturers need to focus on developing innovative and cost-effective APIs, while ensuring compliance with regulatory requirements. The API manufacturers also need to focus on expanding their presence in emerging markets and investing in research and development to develop new drugs and APIs.
?
However, the API market is also facing a range of challenges, such as the stringent regulatory requirements, intellectual property concerns, and the increasing competition. To remain competitive in the API market, API manufacturers need to focus on developing innovative and cost-effective APIs, while ensuring compliance with regulatory requirements. They also need to focus on expanding their presence in emerging markets and investing in research and development to develop new drugs and APIs.
?
?
Conclusion
The API market is a rapidly growing industry, driven by the increasing demand for generic drugs, the rising incidence of chronic diseases, and advancements in technology. The API market is highly fragmented, with a large number of local and global players. The key players in the API market are focusing on strategic initiatives, such as mergers and acquisitions, collaborations, and partnerships, to expand their product portfolios and increase their market share. The increasing prevalence of chronic diseases, the growing demand for generic drugs, and the advancements in technology are the major drivers of the API market. However, the stringent regulatory requirements and intellectual property concerns are the major restraints for the growth of the API market. The growing demand for specialty drugs and the emerging markets are presenting significant opportunities for the growth of the API market.
?
Visit the page Select and Choose the Right Business Startup for You for sorting out the questions arising in your mind before starting any business and know which start-up you can plan.
领英推荐
We, at NPCS, endeavor to make business selection a simple and convenient step for any entrepreneur/startup. Our expert team, by capitalizing on its dexterity and decade's long experience in the field, has created a list of profitable ventures for entrepreneurs who wish to diversify or venture. The list so mentioned is updated regularly to give you a regular dose of new emerging opportunities.
?
?
Reasons for Buying NIIR Report:
?
● Our research report helps you get a detailed picture of the industry by providing an overview of the industry along with the market structure and classification.
● Our report provides market analysis covering major growth driving factors for the industry, the latest market trends and the regulatory framework of the industry.
● Our Report provides an analysis and in-depth financial comparison of major Players / Competitors.
● Our Report provides indispensable buyers' data with their company financials as well as the contact details, which can be an important tool in identifying the target customers.
● Our report provides forecasts of key parameters which help to anticipate the industry performance.
● We use reliable sources of information and databases. And information from such sources is processed by us and included in the report.
?
See More Links:
·????????Start a Business in Asia
·????????Best Industry for Doing Business
·????????Startup Consulting Services
·????????Start a Business in Africa
·????????Start a Business in India
·????????Start a Business in Middle East
·????????Related Videos
·????????Related Books
·????????Related Projects
·????????Related Market Research Reports
?????????????? ????
NIIR PROJECT CONSULTANCY SERVICES, DELHI
An ISO 9001:2015 Company
ENTREPRENEUR INDIA
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: [email protected]
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: https://www.entrepreneurindia.co?
?
?
?
OF_20Art23